Biobot Analytics, Inc.

Somerville, MA · Founded 2017 · Digital health · Private

Wastewater-based epidemiology platform that measures drug metabolites in sewage to quantify population-level substance use

Claim this profile

Follows are private to you and power your alerts

Updated Oct 23, 2026 · biobot.io

Sector: Digital health
Headquarters: Somerville, MA
Founded: 2017
Latest Form D: $13.5M, Jun 2025
Total capital: $38.4M

Federal grants: $2.1M; 4 awards · 2020–2022; Rank in peer group#1 of 16
Private capital raised: $36.3M; 3 Form D · last Jun 2025; 17 months since last filing
Federal contracts: None on recordNo federal contract awards found.
Granted patents: 1; 4 pending · first 2023; Rank in peer group#7 of 16

Capital timeline

Latest events

Jun 2025Private capital raisedForm D · SEC · 3rd filing$13.5M
Feb 2022Federal grantHealth and Human S · Phase II · A novel robotic wastewater analysis system to quantify opioid exposure and treatment in residential communities$175K
Jan 2022Federal grantHealth and Human S · Phase II · A novel robotic wastewater analysis system to quantify opioid exposure and treatment in residential communities$362K
Aug 2021Private capital raisedForm D · SEC · 2nd filing$16.1M
Jan 2021Federal grantHealth and Human S · Phase II · A novel robotic wastewater analysis system to quantify opioid exposure and treatment in residential communities$1.3M
Apr 2020Private capital raisedForm D · SEC · 1st filing$6.7M
Apr 2020Federal grantHealth and Human S · Phase II · A novel robotic wastewater analysis system to quantify opioid exposure and treatment in residential communities$212K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Federal first

<1months

from Biobot Analytics, Inc.’s first federal award to its first private round.

First federal award · Apr 2020: Health and Human S · $212K
First Form D · Apr 2020: $6.7M · 1st Form D
Awards before first raise: 1 award

An association in public records, not a cause or a prediction.

Standing among 16 peers

Line = median

Digital health · Platform

Federal grants#1 · top 6%
Granted patents#7 · top 44%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

Researcher links verified by same-company patents and grants

Mariana Guadalupe Matus GarciaResearcherExecutive Officer, DirectorLinked by 1 patent · $749K in grants as PI
Andrew Guadalupe PerlmanDirectorNamed in SEC Form D filings
Ann Guadalupe DeWittDirectorNamed in SEC Form D filings
Newsha Guadalupe GhaeliExecutive Officer, DirectorNamed in SEC Form D filings
Rich-Henry Guadalupe SchabowskyDirectorNamed in SEC Form D filings
Vivek Guadalupe PattipatiDirectorNamed in SEC Form D filings

What it has protected

USPTO · 1 granted of 5

Oct 12, 2023PendingModular System For Upstream Wastewater SamplingUSPTOApplication 18209831
Aug 1, 2023GrantedModular System For Upstream Wastewater SamplingUSPTOUS 11,714,030
Dec 10, 2020PendingMethod For Characterizing The Prevalence Of A Biochemical Condition Within A PopulationUSPTOApplication 16893308

Show all 5 patent records

Modular System For Upstream Wastewater SamplingOct 12, 2023 · Application 18209831Pending
Modular System For Upstream Wastewater SamplingAug 1, 2023 · US 11,714,030Granted
Method For Characterizing The Prevalence Of A Biochemical Condition Within A PopulationDec 10, 2020 · Application 16893308Pending
Method For Characterizing Drug Usage Within A Geographical RegionApplication 62857216Pending
Modular System For Upstream Wastewater SamplingApplication 62712959Pending

Listen.md, Inc.Similar federal contract value in Digital health · null in contracts
Lucem Health, Inc.Similar federal contract value in Digital health · null in contracts
GENHEALTH, INC.Similar federal contract value in Digital health · null in contracts
Siftwell Analytics, Inc.Similar federal contract value in Digital health · null in contracts
M5 ENTERPRISE, LLC D/B/A EMEDICAL SENTRYSimilar federal contract value in Digital health · null in contracts
GEN NINE, INC.Similar federal contract value in Digital health · null in contracts

Regulatory activity · Digital health

Sector-level, not company-level

07 Jul 2026New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
30 Jun 2026Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
30 Jun 2026Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
29 Jun 2026Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
26 Jun 2026Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
26 Jun 2026Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through Oct 23, 2026. SBIR and STTR awards through Oct 21, 2026.